Bogachan Sahin majored in molecular biology as an undergraduate at Princeton University. He completed his M.D. and Ph.D. training at the University of Texas Southwestern Medical Center at Dallas, where he studied motor learning, synaptic plasticity, and post-synaptic signal transduction in the striatum as a graduate student. After completing his neurology residency and stroke fellowship at Johns Hopkins University, he joined the faculty of the Department of Neurology at the University of Rochester Medical Center in 2013. He is currently serving as Chief of Neurology and Stroke Center Director at Highland Hospital and Director of the Vascular Neurology Fellowship Program in the School of Medicine and Dentistry. His clinical interests include stroke in the young, cerebral vasculopathies, and hereditary stroke disorders. His research is currently focused on mechanisms of visual recovery in stroke survivors, occult atrial fibrillation as a cause of cryptogenic stroke, and carotid revascularization in asymptomatic carotid disease.

Professional Background

Certified Specialties

Neurology - American Board of Psychiatry & Neurology

Vascular Neurology - American Board of Psychiatry & Neurology

Faculty Appointments

Associate Professor - Department of Neurology, Stroke Division (SMD)

Associate Professor - Department of Neurosurgery (SMD) - Joint

Credentials

Residency & Fellowship

Fellowship, Vascular Neurology, Johns Hopkins Hospital. 2012 - 2013

Residency, Neurology, Johns Hopkins Hospital. 2009 - 2012

Internship, Internal Medicine, University of Texas Southwestern Medical Center. 2008 - 2009

Education

MD | University of Texas Southwestern Medical School. 2008

Publications

Journal Articles

Role of non-classical monocytes in HIV-associated vascular cognitive impairment.

Singh MV, Uddin MN, Vidalle MC, Sutton KR, Boodoo ZD, Peterson AN, Tyrell A, Brenner R, Tivarus ME, Wang HZ, Sahin B, Zhong J, Weber M, Wang L, Qiu X, Maggiwar SB, Schifitto G

medRxiv : the preprint server for health sciences.. 2023 March 27 Epub 03/27/2023.

Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.

Van Mieghem NM, Deeb GM, Søndergaard L, Grube E, Windecker S, Gada H, Mumtaz M, Olsen PS, Heiser JC, Merhi W, Kleiman NS, Chetcuti SJ, Gleason TG, Lee JS, Cheng W, Makkar RR, Crestanello J, George B, George I, Kodali S, Yakubov SJ, Serruys PW, Lange R, Piazza N, Williams MR, Oh JK, Adams DH, Li S, Reardon MJ,

JAMA cardiology.. 2022 August 24 Epub 08/24/2022.

FLUORESCE: A Pilot Randomized Clinical Trial of Fluoxetine for Vision Recovery After Acute Ischemic Stroke.

Schneider CL, Prentiss EK, Busza A, Williams ZR, Mahon BZ, Sahin B

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.. 2022 July 8 Epub 07/08/2022.

Increased risk for cerebral small vessel disease is associated with quantitative susceptibility mapping in HIV infected and uninfected individuals.

Murray KD, Uddin MN, Tivarus ME, Sahin B, Wang HZ, Singh MV, Qiu X, Wang L, Spincemaille P, Wang Y, Maggirwar SB, Zhong J, Schifitto G

NeuroImage. Clinical.. 2021 August 2832 :102786. Epub 08/28/2021.

Predictors of Atrial Fibrillation During Long-Term Implantable Cardiac Monitoring Following Cryptogenic Stroke.

Riordan M, Opaskar A, Yoruk A, Younis A, Ali A, McNitt S, Sahin B, Rosero S, Goldenberg I, Aktas MK

Journal of the American Heart Association.. 2020 July 21 :e016040. Epub 07/21/2020.

Pathomechanisms of HIV-Associated Cerebral Small Vessel Disease: A Comprehensive Clinical and Neuroimaging Protocol and Analysis Pipeline.

Murray KD, Singh MV, Zhuang Y, Uddin MN, Qiu X, Weber MT, Tivarus ME, Wang HZ, Sahin B, Zhong J, Maggirwar SB, Schifitto G

Frontiers in neurology. 2020 11 :595463. Epub 12/15/2020.

Selective serotonin reuptake inhibitors for functional recovery after stroke: similarities with the critical period and the role of experience-dependent plasticity.

Schneider CL, Majewska AK, Busza A, Williams ZR, Mahon BZ, Sahin B

Journal of neurology.. 2019 July 25 Epub 07/25/2019.

Survival of retinal ganglion cells after damage to the occipital lobe in humans is activity dependent.

Schneider CL, Prentiss EK, Busza A, Matmati K, Matmati N, Williams ZR, Sahin B, Mahon BZ

Proceedings. Biological sciences. 2019 February 27286 (1897):20182733. Epub 1900 01 01.

Using Vision to Study Poststroke Recovery and Test Hypotheses About Neurorehabilitation.

Busza A, Schneider CL, Williams ZR, Mahon BZ, Sahin B

Neurorehabilitation and neural repair.. 2019 February 33 (2):87-95. Epub 1900 01 01.

Spontaneous in-flight accommodation of hand orientation to unseen grasp targets: A case of action blindsight.

Prentiss EK, Schneider CL, Williams ZR, Sahin B, Mahon BZ

Cognitive neuropsychology.. 2018 October 35 (7):343-351. Epub 03/15/2018.

Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.

Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY,

The New England journal of medicine.. 2018 July 19379 (3):215-225. Epub 05/16/2018.

Unruptured intracranial aneurysms and life insurance underwriting.

Scharf E, Pelkowski S, Sahin B

Neurology. Clinical practice.. 2017 June 7 (3):274-277. Epub 1900 01 01.

An Adenosine-Mediated Glial-Neuronal Circuit for Homeostatic Sleep.

Bjorness TE, Dale N, Mettlach G, Sonneborn A, Sahin B, Fienberg AA, Yanagisawa M, Bibb JA, Greene RW

The Journal of neuroscience : the official journal of the Society for Neuroscience.. 2016 March 3036 (13):3709-21. Epub 1900 01 01.

Ethical considerations in stroke patients.

Kelly AG, Sahin B, Holloway RG

Current opinion in neurology.. 2014 February 27 (1):61-5. Epub 1900 01 01.

The preoperative neurological evaluation.

Probasco J, Sahin B, Tran T, Chung TH, Rosenthal LS, Mari Z, Levy M

The Neurohospitalist.. 2013 October 3 (4):209-20. Epub 1900 01 01.

Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C.

Sahin B, Hawasli AH, Greene RW, Molkentin JD, Bibb JA

European journal of pharmacology.. 2008 March 10581 (3):270-5. Epub 01/10/2008.

Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling.

Sahin B, Galdi S, Hendrick J, Greene RW, Snyder GL, Bibb JA

Brain research.. 2007 January 191129 (1):1-14. Epub 12/06/2006.

Phosphorylation of protein phosphatase inhibitor-1 by protein kinase C.

Sahin B, Shu H, Fernandez J, El-Armouche A, Molkentin JD, Nairn AC, Bibb JA

The Journal of biological chemistry.. 2006 August 25281 (34):24322-35. Epub 06/13/2006.

Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir.

Lee WM, Polson JE, Carney DS, Sahin B, Gale M

The Journal of infectious diseases.. 2005 September 15192 (6):1088-92. Epub 08/10/2005.

Molecular characterization of recombinant mouse adenosine kinase and evaluation as a target for protein phosphorylation.

Sahin B, Kansy JW, Nairn AC, Spychala J, Ealick SE, Fienberg AA, Greene RW, Bibb JA

European journal of biochemistry. 2004 September 271 (17):3547-55. Epub 1900 01 01.

PKC-alpha regulates cardiac contractility and propensity toward heart failure.

Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, DePaoli-Roach AA, Robbins J, Hewett TE, Bibb JA, Westfall MV, Kranias EG, Molkentin JD

Nature medicine.. 2004 March 10 (3):248-54. Epub 02/15/2004.

Protein kinases talk to lipid phosphatases at the synapse.

Sahin B, Bibb JA

Proceedings of the National Academy of Sciences of the United States of America.. 2004 February 3101 (5):1112-3. Epub 01/26/2004.